昆虫激素模拟化合物十二醇微胶囊的制备与释放行为研究

利用昆虫雌性激素对昆虫进行干扰交配是近年来使用的一种新技术,可替代农药杀虫剂达到高选择性无毒无药灭害的目的.鉴于十二醇(C12H25OH)与简单的昆虫激素化合物十二碳烯醇、十二碳烯二醇等结构相近,使用C12H25OH作为昆虫激素的模拟物,探索使用聚合物微球水分散体系将昆虫激素模拟物C12H25OH包覆在聚合物微球中,通过改变水分散体系的制备方法、复合微球壁的交联度等探讨了此类体系对C12H25OH的可控释放.首先通过测定阿拉伯胶明胶复凝聚过程的透光率、ζ电位,确定了阿拉伯胶-明胶的质量配比为1时可达最大复凝聚.在此基础上,制备了一系列交联剂戊二醛含量不同的复合微胶囊.结果表明微胶囊壁材的交联度随交联剂量明显上升,其对C12H25OH的包覆率经1%戊二醛交联后即提高至未交联体系的约三倍.但进一步提高戊二醛的含量,虽然胶囊的交联度仍明显上升,但对C12H25OH的包覆率基本保持恒定.使用同样量的甲醛可达同样交联效果,但对C12H25OH的包覆率有明显提高.在恒温恒湿条件下对各胶囊的C12H25OH释放行为进行了表征,结果显示交联胶囊可明显提高C12H25OH的恒速释放时间,交联度越高,恒速释放越稳定.本工作表明通过本方法确实可以达到将昆虫激素包覆在聚合物颗粒中并达到可控释放.     

昆虫激素十二醇微胶囊的制备与释放行为研究

利用昆虫雌性激素对昆虫进行干扰交配是近年来使用的一种新技术,可替代农药杀虫剂达到高选择性无毒无药灭害的目的。迄今为止的相关研究及应用技术都是使用载有昆虫激素的棉条、纸片、塑胶管等装置,以一定密度置于果园或农田。十二醇是较为简单的一个存在于多种昆虫的雌性激素中化合物。本文首次探索使用聚合物微球水分散体系将昆虫激素十二醇(C12OH)包覆在聚合物微球中,通过改变水分散体系的制备方法、复合微球壁的交联度等探讨了此类体系对C12OH的可控释放。本工作首先通过测定阿拉伯胶明胶复凝聚过程的透光率、ζ电位,确定了阿拉伯胶-明胶的重量配比为1时可达最大复凝聚。在此基础上,制备了一系列不同交联剂戊二醛含量的复合微胶囊。结果表明微胶囊壁材的交联度随交联剂量明显上升,其对C12OH的包覆率经1%戊二醛交联后即提高至未交联体系的约三倍。但进一步提高戊二醛的含量,虽然胶囊的交联度仍明显上升,但对C12OH的包覆率基本保持恒定。使用同样量的甲醛可达同样交联效果,但对C12OH的包覆率有明显提高。在恒温恒湿条件下对各胶囊的C12OH释放行为进行了表征,结果显示交联胶囊可明显提高C12OH的恒速释放时间,交联度越高,恒速释放越稳定。本工作表明通过本方法确实可以达到将昆虫激素包覆在聚合物颗粒中并达到可控释放。     

聚[2-(甲基丙烯酰氧)乙基三甲基氯化铵]/阿拉伯胶复凝聚法十二醇微胶囊的制备

将聚[2-(甲基丙烯酰氧)乙基三甲基氯化铵](PMTC)和阿拉伯胶(GA)在一定条件下进行了复凝聚,并对影响复凝聚实验的壁材配比、壁材浓度、离子强度等因素进行了考察.实验结果表明,PMTC与GA配比为1/3.22,壁材总浓度为4%时复凝聚效率最高;体系中不同浓度的氯化钠的存在会对复凝聚起到不同程度的抑制作用.在实验确定的最佳复凝聚条件下以有机小分子化合物十二醇作为芯材进行了包覆,制备了不同壁芯比例的微胶囊.对微胶囊的包覆率及载药量进行了测量,并对它们的释放行为进行了考察.包覆有十二醇的复合微胶囊大小一般在几微米.随着壁材与芯材比例的增大,胶囊载药量逐渐降低,微胶囊释放十二醇的速率明显变小,但包覆率却无明显变化规律.     

单凝聚与复凝聚法制备昆虫激素十二醇微胶囊及其释放行为

通过向明胶溶液中加入硫酸钠溶液的单凝聚方法以及将明胶溶液加入到阿拉伯胶溶液的复凝聚方法,制备了聚合物包覆昆虫激素十二醇的水分散体系微胶囊.通过对凝聚过程中ζ电位与透光率跟踪测试确定了单凝聚中加入硫酸钠的最佳用量以及复凝聚中明胶与阿拉伯胶的相对量.在壁材浓度大于或等于3%条件下制备的复凝聚胶囊的尺寸大于单凝聚微胶囊,但后者的大小分布更均一.除非在2%壁材浓度下,其他条件下复凝聚制备的胶囊的十二醇包覆率明显高于单凝聚胶囊.对胶囊中十二醇在恒湿恒温条件下的释放研究表明,单凝聚胶囊中十二醇很快释放完毕,变化壁材浓度不明显改变其释放行为.相比之下复凝聚胶囊中十二醇的释放对壁材浓度有明显的依赖性.2%壁材浓度制备的胶囊其释放行为类似于单凝聚胶囊;但3%到5%壁材浓度制备的胶囊中十二醇的释放明显分为3个区间,即较快的初始释放、较长时间的恒速释放以及最后阶段释放速率的再次提高直至释放完毕.复凝聚胶囊中十二醇的释放表现出了明显的可控性.文中亦对该体系中昆虫激素十二醇的释放机理作了初步讨论.     

大豆分离蛋白-十二烷基硫酸钠微胶囊的制备与表征

以大豆分离蛋白(SPI)和十二烷基硫酸钠(SDS)为壁材, 以十六烷为芯材, 通过复凝聚法制备了微胶囊. 首先确定了SPI和SDS发生复凝聚的适宜pH、SPI/SDS配比、壁材浓度等. 在确定的实验条件下进行复凝聚, 凝聚物产率可达85%. 改变搅拌转速和芯壁比, 考察它们对微胶囊性能的影响. 用光学显微镜观察了微胶囊形貌. 用气相色谱测定了微胶囊的载药量和包覆率. 芯壁比为2、搅拌转速为400 r/min时所制备微胶囊的载药量可达61%. 随着芯壁比的增大, 微胶囊粒径及载药量都逐渐增大.     

乳清蛋白/阿拉伯胶复凝聚法制备载乙酸油酯微胶囊及其表征

油醇(十八烯醇)与乙酸酐的摩尔比为1/1.7,催化剂对甲苯磺酸用量为油醇与乙酸酐总质量的0.2%,25℃反应3h合成了昆虫性激素成分之一的乙酸油酯并对其进行了表征.以高分子电解质乳清蛋白(WP)和阿拉伯胶(GA)进行复凝聚制备聚合物微胶囊,对影响复凝聚的pH、两种电解质的配比及其浓度等因素进行了考察.结果表明在pH=3.5,WP/GA质量比1.5,WP和GA总浓度1.0%时复凝聚效果最佳.在该条件下以WP/GA为壁材对乙酸油酯进行了包覆,制备了不同壁材总浓度的载油微胶囊,对微胶囊的载油量和包覆率进行了测量.随着壁材总浓度的增大,芯材乙酸油酯包覆率呈现先上升后下降的变化趋势.用扫描电镜观察,发现制备的载乙酸油酯微胶囊大小在5～8μm并且乙酸油酯以核壳式结构的形式被包覆在微胶囊内部.     

高效氯氰菊酯微胶囊的制备、表征及释放性能

以高效氯氰菊酯为芯材, 乙基纤维素为壁材, 采用溶剂蒸发法制备了微胶囊, 并对其理化性能进行表征, 通过单因素实验研究了工艺参数对微胶囊外观形貌、 粒径大小及分布、 包封率、 载药量和缓释性能的影响. 结果表明, 乳化剂种类和剪切时间可以显著影响微胶囊的外观形貌; 随着乳化剂用量增大, 微胶囊粒径减小, 分布变窄, 当Tween-80用量从4%增加至8%时, 微胶囊平均粒径从59.9 μm减少到29.8 μm, 跨距也从1.21减少到0.72. 随着芯壁比(质量比)减小, 微胶囊粒径和包封率均逐渐增大, 载药量逐渐减小, 当芯壁比为1:1.75时, 包封率可以达到70%以上. 微胶囊释放动力学模型符合Ritger-Peppas模型(lgQ=lgk+nlgt); 平均粒径相近而载药量不同时, 初期载药量最小的样品释放速率慢, 累积释放率低; 载药量相近而平均粒径不同时, 粒径大的样品释放速率低, 累积释放率也低.     

不同相对分子质量羟乙基纤维素对甲维盐微胶囊制备的影响

采用原位聚合法以三聚氰胺-甲醛树脂为壁材制备了甲维盐微胶囊。 探讨了不同黏均相对分子质量羟乙基纤维素作为乳化剂对微胶囊表面形貌、粒径及其分布、包覆率与载药量的影响,对使用不同黏均相对分子质量羟乙基纤维素作为乳化剂制备的微胶囊的释放性能进行了表征。 结果表明,以相对分子质量较小的羟乙基纤维素制备的微胶囊外形规则、致密且无黏连现象。 随羟乙基纤维素黏均相对分子质量的增加所得微胶囊的平均粒径及粒径分布逐渐增大,包覆率与载药量逐渐减小。 释放性能的研究表明,采用相对分子质量较小的羟乙基纤维素制备的微胶囊的释放性能较好。     

复凝聚法辣椒油树脂微胶囊的制备

以辣椒油树脂为芯材,明胶和阿拉伯胶为壁材,采用复凝聚法制得辣椒油树脂微胶囊.考察了45℃、体系浓度为5%时,pH值、乳化剂的用量、搅拌速度等几个因素对微胶囊形成的影响.     

以聚脲为囊壁薄荷素油微胶囊的制备及表征

采用界面聚合法,以薄荷素油为芯材,以异佛尔酮二异氰酸酯为壁材单体,在催化剂四甲基乙二胺作用下和水反应形成聚脲外壳,制备出了薄荷素油微胶囊.通过扫描电镜、激光粒度分析仪、傅里叶红外光谱仪及热重分析仪分别对香精微胶囊的表面形貌、粒径分布、单体反应情况和热稳定性进行了分析表征.通过紫外可见分光光度计对香精微胶囊包覆率进行了测定.并分析了均质化速率和微胶囊平均粒径的关系以及不同乳化剂种类和芯壁比条件下微胶囊的形貌特征.结果表明,微胶囊平均粒径随均质化速率的增大而减小,下降到1μm左右时趋于平稳,当乳化剂采用聚乙烯醇且芯壁比为4∶1时,微胶囊形貌最佳,为规整球形.最终测得微胶囊芯材包覆率为84.09 wt%,粉末状微胶囊样品含油率为72.64 wt%,并且微胶囊芯材具有良好的热稳定性.     

Study of Complex Coacervation of Gelatin A and Sodium Alginate for Microencapsulation of Olive Oil

Complex coacervation of gelatin A and sodium alginate was carried out to obtain the maximum coacervate yield. Turbidity and coacervate yield (%) measurements were carried out to support the ratio of the two polymers and pH that produced maximum coacervation. The optimum ratio between gelatin A-sodium alginate and pH to form the maximum coacervate complex was found to be 3.5:1 and 3.5–3.8, respectively. Olive oil microencapsulation was carried out at the optimized ratio and pH. Microcapsules were crosslinked by using glutaraldehyde. Scanning electron microscopy studies confirmed the formation of free flowing spherical microcapsules of different sizes. The size of microcapsules increased with the increase in the concentration of the polymer. The encapsulation efficiency and the release rates of olive oil were dependent on the amount of crosslinker, oil loading and polymer concentration. Thermogravimetric study revealed improvement of thermal stability with crosslinking. Fourier Transform Infrared Spectroscopy study showed that there was no significant interaction between olive oil and gelatin-alginate complex.     

Microencapsulation of dodecyl acetate by complex coacervation of whey protein with acacia gum and its release behavior

Complex coacervation of whey protein(WP) with acacia gum(AG) was carried out in water with the presence of dodecyl acetate (DA),a component of insect sex pheromones,in order to obtain microcapsules with DA as the core material and WP-AG coacervate as the wall materials.Through variations in wall/core ratios,concentrations of the wall materials in capsule preparations,DA encapsulation was optimized,which showed a high DA encapsulation was achieved when coacervation was conducted at pH 3.5 with wall/core mass ratio at 3 combined with concentration of wall materials at 1.0 wt%.Morphology and the structure of DA loaded microcapsules were examined by scanning electron microscope,which showed the microcapsules were of core/shell structure with DA encapsulated in the inner of the microcapsules.DA release was examined and the behavior of the release was discussed.     

Manipulating the properties of coacervated polyelectrolyte microcapsules by chemical crosslinking

The properties of coacervated sodium poly(styrene sulfonate) (PSS)/poly(allylamine hydrochloride) (PAH) microcapsules were manipulated by glutaraldehyde crosslinking at mild conditions. Although the crosslinking took place only between the PAH component, only 10% of PSS was lost from the 2-h crosslinked microcapsules. Significant variation in terms of capsule morphology, diameter, and wall thickness was not found by scanning electron microscopy and scanning force microscopy. Although all the microcapsules were not affected by annealing at 70 °C and incubation in 0.1 M HCl for 2 h, the crosslinked microcapsules indeed showed strong ability to resist osmotic-induced capsule invagination. Also, the 20-min and 2-h crosslinked capsule walls have elasticity modulii of 166 and 200 MPa, respectively, which are both larger than that of the original one (140 MPa). The crosslinked microcapsules also showed good stability in 0.01 M NaOH solution and poorer permeability for a large fluorescent probe.     

Effect of Crosslinking Agent on Neem (Azadirachta Indica A. Juss.) Seed Oil (NSO) Encapsulated Microcapsules of κ -Carrageenan and Chitosan Polyelectrolyte Complex

Microencapsulation of neem (Azadirachta Indica A. Juss.) seed oil (NSO) was carried out by polyelectrolyte complexation of κ -carrageenan and chitosan. The microcapsules were crosslinked by using three different crosslinking agents - glutaraldehyde, genipin and tannic acid. The lowest and highest water uptake capacities were exhibited by glutaraldehyde and tannic acid crosslinked matrices, respectively. The release behavior of NSO from encapsulated crosslinked microcapsules followed the order: tannic acid > genipin > glutaraldehyde. Polyelectrolyte complex formation and its interaction with crosslinker was studied. Crosslinking improved thermal stability without affecting crystallinity. Roughness appeared on microcapsule's surface indicated interaction between microcapsules and crosslinker.     

甲胺基阿维菌素苯甲酸盐微胶囊的制备与表征

以三聚氰胺-甲醛树脂为壁材,采用原位聚合法制备了甲胺基阿维菌素苯甲酸盐微胶囊,研究了三聚氰胺与甲醛的质量比、芯壁比、乳化剂、搅拌速度与时间、pH值、温度等因素对微胶囊形成的影响,对制备的微胶囊进行了表征,测定了甲维盐微胶囊化前后的光解率。结果表明,三聚氰胺与甲醛质量比为1∶2、芯材与壁材质量比为3∶2、以质量分数1%羟乙基纤维素(HEC)为乳化剂、在1000r/min搅拌速度下、pH=5.0和50℃保温2h可制备出形貌较好、平均粒径4.4μm的甲维盐微胶囊。红外光谱分析证明,甲维盐已完全被包覆在微胶囊中。紫外分光光度法测定其缓释性能良好。光解实验表明,微胶囊化可有效降低甲维盐原药的光解。